Compare / See the difference

SAME CATEGORY?
LOOK AGAIN.

Put two signaling stories next to each other and look for the actual difference.

Signal comparison / 03

WHAT DOES THE THIRD SIGNAL CHANGE?

Tirzepatide and retatrutide make a clear two-versus-three-receptor comparison.

01

Tirzepatide

Starting signal
GIP + GLP-1 receptors
Plain-language role
Two incretin receptor targets.
Evidence in this story
Described in FDA prescribing information.
Read Tirzepatide ↗
02

Retatrutide

Starting signal
GIP + GLP-1 + glucagon receptors
Plain-language role
A third receptor target adds a distinct research question.
Evidence in this story
Published randomized Phase 2 research.
Read Retatrutide ↗
What this comparison cannot tell you

Receptor count alone cannot compare efficacy or safety across different trials.

Beyond the field guide / Community

MORE QUESTIONS? TALK IT THROUGH.

Explore GLP-1 and peptide discussions, ask questions, and read shared experiences on glp1chat.

Visit glp1chat Independent forum · Opens in a new tab